{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:23:34Z","timestamp":1794007414849,"version":"4.8.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008723","name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019841","name":"Suomalais-Norjalainen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/100019841","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012691","name":"OLVI-S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/501100012691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007639","name":"Maire Taposen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/501100007639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010129","name":"Maud Kuistilan Muistos\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/100010129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008320","name":"Suomen Aivos\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/501100008320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008320","name":"Suomen Aivos\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["20190012"],"award-info":[{"award-number":["20190012"]}],"id":[{"id":"10.13039\/501100008320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008320","name":"Suomen Aivos\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/501100008320","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ALS tutkimuksen tuki ry","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["339767"],"award-info":[{"award-number":["339767"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["325022"],"award-info":[{"award-number":["325022"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["315460"],"award-info":[{"award-number":["315460"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["315459"],"award-info":[{"award-number":["315459"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004092","name":"Kuopion Yliopistollinen Sairaala","doi-asserted-by":"publisher","award":["VTR"],"award-info":[{"award-number":["VTR"]}],"id":[{"id":"10.13039\/501100004092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010114","name":"Yrj\u00f6 Jahnssonin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/100010114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007083","name":"Orionin Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008413","name":"Instrumentariumin Tiedes\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/501100008413","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with various clinical and neuropathological subtypes. The two major pathological proteins accumulating in the brains of FTD patients, depending on their genetic background, are TDP-43 and tau. We aimed to evaluate whether total TDP-43 levels measured from the serum associate with the genotype or clinical phenotype of the FTD patients and whether serum TDP-43 provides prognostic or diagnostic value in the FTD spectrum disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study cohort included 254 participants with a clinical diagnosis of FTD (including all major genotypes and clinical phenotypes) and 105 cognitively healthy controls. Serum total TDP-43 levels measured with a single-molecule array (Simoa) were compared within the FTD group according to the genotype, clinical phenotype, and predicted neuropathological subtype of the patients. We also evaluated the associations between the TDP-43 levels and disease severity or survival in FTD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Total TDP-43 levels in the serum were significantly lower in the FTD group as compared to the healthy control group (275.3 pg\/mL vs. 361.8 pg\/mL, <jats:italic>B<\/jats:italic> = 0.181, 95%CI = 0.014\u20130.348, <jats:italic>p<\/jats:italic> = 0.034). The lowest TDP-43 levels were observed in the subgroup of FTD patients harboring predicted TDP-43 brain pathology (FTD-TDP, 241.4 pg\/mL). The low levels in the FTD-TDP group were especially driven by <jats:italic>C9orf72<\/jats:italic> repeat expansion carriers (169.2 pg\/mL) and FTD patients with concomitant motoneuron disease (FTD-MND, 113.3 pg\/mL), whereas <jats:italic>GRN<\/jats:italic> mutation carriers did not show decreased TDP-43 levels (328.6 pg\/mL). Serum TDP-43 levels showed no correlation with disease severity nor progression in FTD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results indicate that the total levels of TDP-43 in the serum are decreased especially in FTD patients with the <jats:italic>C9orf72<\/jats:italic> repeat expansion or FTD-MND phenotype, both subtypes strongly associated with TDP-43 type B brain pathology. Serum-based measurement of TDP-43 could represent a useful tool in indicating <jats:italic>C9orf72<\/jats:italic> repeat expansion and FTD-MND-related TDP-43 neuropathology for future diagnostics and intervention studies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-022-01091-8","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T02:02:59Z","timestamp":1665453779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype"],"prefix":"10.1186","volume":"14","author":[{"given":"Kasper","family":"Katisko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarja","family":"Kokkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Leena","family":"Heikkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veera","family":"Paananen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville E.","family":"Korhonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Helisalmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna-Kaisa","family":"Herukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Cantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Gadola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Archetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Remes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annakaisa","family":"Haapasalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eino","family":"Solje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"issue":"10004","key":"1091_CR1","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","volume":"386","author":"J Bang","year":"2015","unstructured":"Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015;386(10004):1672\u201382.","journal-title":"Lancet."},{"key":"1091_CR2","doi-asserted-by":"publisher","unstructured":"Irwin DJ, Cairns NJ, Grossman M, McMillan CT, Lee EB, Van Deerlin VM, et al. Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol. 2015;129(4):469\u201391. https:\/\/doi.org\/10.1007\/s00401-014-1380-1.","DOI":"10.1007\/s00401-014-1380-1"},{"key":"1091_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00401-012-1029-x","volume":"124","author":"A Sieben","year":"2012","unstructured":"Sieben A, Van Langenhove T, Engelborghs S, Martin JJ, Boon P, Cras P, et al. The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol. 2012;124:353\u201372.","journal-title":"Acta Neuropathol"},{"key":"1091_CR4","doi-asserted-by":"publisher","unstructured":"Josephs KA, Hodges JR, Snowden JS, MacKenzie IR, Neumann M, Mann DM, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122(2):137\u201353. https:\/\/doi.org\/10.1007\/s00401-011-0839-6.","DOI":"10.1007\/s00401-011-0839-6"},{"key":"1091_CR5","doi-asserted-by":"publisher","unstructured":"Katisko K, Cajanus A, J\u00e4\u00e4skel\u00e4inen O, Kontkanen A, Hartikainen P, Korhonen VE, et al. Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders. J Neurol. 2020;267(1):162\u20137. https:\/\/doi.org\/10.1007\/s00415-019-09567-8.","DOI":"10.1007\/s00415-019-09567-8"},{"key":"1091_CR6","doi-asserted-by":"publisher","unstructured":"Cajanus A, Katisko K, Kontkanen A, J\u00e4\u00e4skel\u00e4inen O, Hartikainen P, Haapasalo A, et al. Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis. Ann Clin Transl Neurol. 2020;7(6):903\u201310. https:\/\/doi.org\/10.1002\/acn3.51041.","DOI":"10.1002\/acn3.51041"},{"key":"1091_CR7","doi-asserted-by":"publisher","unstructured":"Katisko K, Cajanus A, Huber N, J\u00e4\u00e4skel\u00e4inen O, Kokkola T, K\u00e4rkk\u00e4inen V, et al. GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance. J Neurol Neurosurg Psychiatry. 2021;92(12):1305\u201312. https:\/\/doi.org\/10.1136\/jnnp-2021-326487.","DOI":"10.1136\/jnnp-2021-326487"},{"key":"1091_CR8","doi-asserted-by":"publisher","unstructured":"Heller C, Foiani MS, Moore K, Convery R, Bocchetta M, Neason M, et al. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2020;91(3):263\u2013270. https:\/\/doi.org\/10.1136\/jnnp-2019-321954.","DOI":"10.1136\/jnnp-2019-321954"},{"key":"1091_CR9","doi-asserted-by":"publisher","unstructured":"Ashton NJ, Janelidze S, Al Khleifat A, Leuzy A, van der Ende EL, Karikari TK, et al. A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun. 2021;12(1):3400. https:\/\/doi.org\/10.1038\/s41467-021-23620-z.","DOI":"10.1038\/s41467-021-23620-z"},{"key":"1091_CR10","doi-asserted-by":"publisher","unstructured":"Benussi A, Ashton NJ, Karikari TK, Gazzina S, Premi E, Benussi L, et al. Serum glial fibrillary acidic protein (GFAP) is a marker of disease severity in frontotemporal lobar degeneration. J Alzheimers Dis. 2020;77(3):1129\u20131141. https:\/\/doi.org\/10.3233\/JAD-200608.","DOI":"10.3233\/JAD-200608"},{"key":"1091_CR11","doi-asserted-by":"publisher","unstructured":"Rajan KB, Aggarwal NT, McAninch EA, Weuve J, Barnes LL, Wilson RS, et al. Remote blood biomarkers of longitudinal cognitive outcomes in a population study. Ann Neurol. 2020;88(6):1065\u201376. https:\/\/doi.org\/10.1002\/ana.25874.","DOI":"10.1002\/ana.25874"},{"key":"1091_CR12","doi-asserted-by":"publisher","unstructured":"Feneberg E, Gray E, Ansorge O, Talbot K, Turner MR. Towards a TDP-43-based biomarker for ALS and FTLD. Mol Neurobiol. 2018;55(10):7789\u2013801. https:\/\/doi.org\/10.1007\/s12035-018-0947-6.","DOI":"10.1007\/s12035-018-0947-6"},{"key":"1091_CR13","doi-asserted-by":"publisher","unstructured":"Kuiperij HB, Versleijen AAM, Beenes M, Verwey NA, Benussi L, Paterlini A, et al. Tau rather than TDP-43 proteins are potential cerebrospinal fluid biomarkers for frontotemporal lobar degeneration subtypes: a pilot study. J Alzheimers Dis. 2017;55(2):585\u201395. https:\/\/doi.org\/10.3233\/JAD-160386.","DOI":"10.3233\/JAD-160386"},{"key":"1091_CR14","doi-asserted-by":"publisher","unstructured":"Su\u00e1rez-Calvet M, Dols-Icardo O, Llad\u00f3 A, S\u00e1nchez-Valle R, Hern\u00e1ndez I, Amer G, et al. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation. J Neurol Neurosurg Psychiatry. 2014;85(6):684\u201391. https:\/\/doi.org\/10.1136\/jnnp-2013-305972.","DOI":"10.1136\/jnnp-2013-305972"},{"key":"1091_CR15","doi-asserted-by":"publisher","unstructured":"Ren Y, Li S, Chen S, Sun X, Yang F, Wang H, et al. TDP-43 and phosphorylated TDP-43 levels in paired plasma and CSF samples in amyotrophic lateral sclerosis. Front Neurol. 2021;12:663637. https:\/\/doi.org\/10.3389\/fneur.2021.663637.","DOI":"10.3389\/fneur.2021.663637"},{"issue":"11","key":"1091_CR16","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006\u201314.","journal-title":"Neurology."},{"issue":"9","key":"1091_CR17","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(9):2456\u201377.","journal-title":"Brain."},{"key":"1091_CR18","doi-asserted-by":"publisher","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology. 1996;47(1):1\u20139. https:\/\/doi.org\/10.1212\/wnl.47.1.1.","DOI":"10.1212\/wnl.47.1.1"},{"key":"1091_CR19","doi-asserted-by":"publisher","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2000;1(5):293\u20139. https:\/\/doi.org\/10.1080\/146608200300079536.","DOI":"10.1080\/146608200300079536"},{"issue":"6","key":"1091_CR20","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546\u201354.","journal-title":"Neurology."},{"issue":"1","key":"1091_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1468-1331.2008.02272.x","volume":"16","author":"J Kr\u00fcger","year":"2009","unstructured":"Kr\u00fcger J, Kaivorinne AL, Udd B, Majamaa K, Remes AM. Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration. Eur J Neurol. 2009;16(1):27\u201330.","journal-title":"Eur J Neurol"},{"issue":"11","key":"1091_CR22","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1468-1331.2010.03028.x","volume":"17","author":"AL Kaivorinne","year":"2010","unstructured":"Kaivorinne AL, Kr\u00fcger J, Udd B, Majamaa K, Remes AM. Mutations in CHMP2B are not a cause of frontotemporal lobar degeneration in Finnish patients. Eur J Neurol. 2010;17(11):1393\u20135.","journal-title":"Eur J Neurol"},{"issue":"1","key":"1091_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2377-8-48","volume":"8","author":"A-L Kaivorinne","year":"2008","unstructured":"Kaivorinne A-L, Kr\u00fcger J, Kuivaniemi K, Tuominen H, Moilanen V, Majamaa K, et al. Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland. BMC Neurol. 2008;8(1):48 Available from: http:\/\/www.biomedcentral.com\/1471-2377\/8\/48.","journal-title":"BMC Neurol"},{"issue":"6","key":"1091_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nbt.1641","volume":"28","author":"DM Rissin","year":"2010","unstructured":"Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L, et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol. 2010;28(6):595\u20139.","journal-title":"Nat Biotechnol"},{"key":"1091_CR25","doi-asserted-by":"publisher","unstructured":"Meneses A, O\u2019Leary J, Dickson DW, Bu G, Zhao N. TDP-43 pathology in Alzheimer\u2019s disease. Mol Neurodegener. 2021;16(84). https:\/\/doi.org\/10.1186\/s13024-021-00503-x.","DOI":"10.1186\/s13024-021-00503-x"},{"key":"1091_CR26","doi-asserted-by":"publisher","unstructured":"Geuens T, Bouhy D, Timmerman V. The hnRNP family: insights into their role in health and disease. Hum Genet. 2016;135(8):851\u201367. https:\/\/doi.org\/10.1007\/s00439-016-1683-5.","DOI":"10.1007\/s00439-016-1683-5"},{"key":"1091_CR27","doi-asserted-by":"publisher","unstructured":"Sephton CF, Good SK, Atkin S, Dewey CM, Mayer P, Herz J, et al. TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem. 2010;285(9):6826\u201334. https:\/\/doi.org\/10.1074\/jbc.M109.061846.","DOI":"10.1074\/jbc.M109.061846"},{"key":"1091_CR28","doi-asserted-by":"publisher","unstructured":"Buratti E, Baralle FE. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci. 2008;13:867\u201378. https:\/\/doi.org\/10.2741\/2727.","DOI":"10.2741\/2727"},{"key":"1091_CR29","doi-asserted-by":"publisher","unstructured":"Gendron TF, Josephs KA, Petrucelli L. Review: Transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration. Neuropathol Appl Neurobiol. 2010;36(2):97\u2013112. https:\/\/doi.org\/10.1111\/j.1365-2990.2010.01060.x.","DOI":"10.1111\/j.1365-2990.2010.01060.x"},{"key":"1091_CR30","doi-asserted-by":"publisher","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602\u201311. https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.093.","DOI":"10.1016\/j.bbrc.2006.10.093"},{"key":"1091_CR31","doi-asserted-by":"publisher","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130\u20133. https:\/\/doi.org\/10.1126\/science.1134108.","DOI":"10.1126\/science.1134108"},{"key":"1091_CR32","doi-asserted-by":"publisher","unstructured":"Noto YI, Shibuya K, Sato Y, Kanai K, Misawa S, Sawai S, et al. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value. Amyotroph Lateral Scler. 2011;12(2):140\u20133. https:\/\/doi.org\/10.3109\/17482968.2010.541263.","DOI":"10.3109\/17482968.2010.541263"},{"key":"1091_CR33","doi-asserted-by":"publisher","unstructured":"Foulds PG, Davidson Y, Mishra M, Hobson DJ, Humphreys KM, Taylor M, et al. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathol. 2009;118(5):647\u201358. https:\/\/doi.org\/10.1007\/s00401-009-0594-0.","DOI":"10.1007\/s00401-009-0594-0"},{"key":"1091_CR34","doi-asserted-by":"publisher","unstructured":"Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, et al. Cerebrospinal fluid \u03b2-amyloid((1-42)) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol. 1999;56(6):673\u201380. https:\/\/doi.org\/10.1001\/archneur.56.6.673.","DOI":"10.1001\/archneur.56.6.673"},{"key":"1091_CR35","doi-asserted-by":"publisher","unstructured":"Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:25. https:\/\/doi.org\/10.3389\/fnmol.2019.00025.","DOI":"10.3389\/fnmol.2019.00025"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01091-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-01091-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01091-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T02:08:54Z","timestamp":1665454134000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-01091-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-01091-8","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]},"assertion":[{"value":"10 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of the Northern Savo Hospital District and of the Brescia Hospital approved the research protocol (10.5.2013\/16\/2013), and the study was done in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}